The former upped his price target on Novo Nordisk to 800 Danish kroner ($115) per share from the previous 750 kroner ($108), while the latter raised his to 730 kroner ($105) from 705 kroner ($101). Both maintained their equivalent of a buy recommendation.
Why Novo Nordisk Stock Trounced the Market Today
by
Tags: